期刊文献+

超顺磁性氧化铁(SPIO)对比剂肝脾MR成像的比较研究 被引量:3

A Comparative Study of the Relaxation Effects of Two Superparamagnetic Iron Oxide Agents in MRI of the Liver and Spleen
下载PDF
导出
摘要 目的 比较两种超顺磁性氧化铁 (superparamagneticironoxide ,SPIO)对比剂 ,Ferumoxides及SHU 5 5 5A在肝脾MR成像中的效应。材料与方法  3 6例已知为肝转移癌患者于SPIO造影前后进行T2 WI快速自旋回波成像 (T2 WITSE)及T1WI梯度回波快速去相位成像 (T1WIFLASH)。扫描仪为 1.0TMR机。 18例患者行Ferumoxides增强后 90分钟进行MR成像 ;另 18例行SHU 5 5 5A快速团注增强 ,注药后即刻、3 0秒及 480秒行T1WIFLASH成像 ,10分钟行T2 WITSE成像。测量肝脾、肝转移癌SPIO增强前后的信号强度(signalintensity ,SI) ,计算两种SPIO对比剂在肝脾、肝转移癌增强前后SI变化的百分比 (percentagesignalintensitychange ,PSIC)及病灶 肝脏对比噪声比 (lesion to livercontrast to noiseratio ,CNR)及其变化 (ΔCNR)。结果 在T2 WITSE图像上 ,两种SPIO对比剂造成的肝实质SI下降无显著性差异 (P >0 .0 5 )。Ferumoxides引起的脾信号下降显著大于SHU 5 5 5A(P <0 .0 5 )。两种SPIO对比剂均导致肝转移癌CNR显著增高。T1WIFLASH图像上 ,两种对比剂均可导致延迟像上肝脏SI的轻度下降及肝转移癌CNR下降 ,两者肝脏PSIC之间无显著性差异。T1WI上两种对比剂均可导致脾脏SI显著升高 ,两者脾脏PSIC之间无显著性差异 (P >0 .0 5 ) Objective To compare the enhancement effectiveness of two superparamagnetic iron oxide (SPIO) contrast agents, Ferumoxides and SHU 555A, in MRI of the liver and spleen.Materials and Methods T 2W TSE and T 1WI FLASH scanning were performed in 36 cases with hepatic metastases before and after SPIO contrast injection with a 1.0T MR unit. Post Ferumoxides images were obtained 90 min. After the infusion of the agent with a dose of 15 μmol Fe/kg in 18 cases. In the other 18 cases, T 1W FLASH images were obtained at 0, 30, and 480 sec. After a bolus injection of SHU 555A with a dose of 7.0~12.9 μmol Fe/kg, while T 2W TSE images were obtained at 10 min. After the injection. Signal intensity of the liver, spleen and hepatic metastatic lesions was measured with an operator defined region of interest both before and after SPIO admistration. The enhancement effects of Ferumoxides and SHU 555A were expressed as the percentage of signal intensity change (PSIC) of the liver and spleen, the PSIC of the malignant liver lesions, and the changes in lesion to liver contrast to noise ratio (ΔCNR).Results No significant difference in signal loss of liver parenchyma between the two agents was found on T 2W TSE images, (P> 0.05). Both SPIO agents produced a significant increase in the CNR of malignant liver lesions. ΔCNR in Ferumoxides group was slightly greater than that in SHU 555A group (P< 0.05). On T 1W FLASH images, a slight decrease of liver SI induced by the two agents was seen on late post SPIO images. No significant difference in liver PSIC between two groups was noted onT 1W images. The CNR of hepatic metastatic lesions was decreased in both groups on T 1W images. The SI of spleen was significantly increased in both groups on T 1W images and no difference in PSIC of spleen was noted (P>0.05).Conclusion Ferumoxides and SHU 555A have similar T 1 and T 2 enhancement effects for the liver, while Ferumoxides carries a stronger T 2 enhancement effects for the spleen than SHU 555A does.
出处 《临床放射学杂志》 CSCD 北大核心 2001年第3期191-195,共5页 Journal of Clinical Radiology
基金 国家教委留学基金资助! (No.96832 0 1 5)
关键词 肝脏 脾脏 肝肿瘤 对比剂 磁共振成像 超顺磁性氧化铁 Liver Spleen MRI Hepatic tumors Contrast agent Enhancement Iron
  • 相关文献

参考文献10

  • 1[1]Reimer P, Rummeny EJ, Daldrup HE,et al. Clinical results with Resovist: A phase 2 clinical trial. Radiology, 1995, 195:489
  • 2[2]Grangier C, Tourniaire J, Mentha G,et al. Enhancement of liver haemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. JCAT, 1994, 18:888
  • 3[3]Thickman D, Hendrick RE, Jerjian KA,et al. Liver-lesion tissue contrast on MR images: Effect of iron oxide concentration and magnetic field strength. Radiology, 1990, 176:557
  • 4[4]Oudkerk M, Van den Heuvel AG, Wielopolski PA,et al. Hepatic lesions: Detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology, 1997, 203:449
  • 5[5]Chambon C, Clement O, Blanche AL,et al. Superparamagnetic iron oxide as positive MR contrast agents: In vitro and in vivo evidence. Magn Res Imag, 1993, 11:509
  • 6[6]Bach-Gansmo T, Fahlvik A, Ericsson A,et al. Superparamagnetic iron oxide for liver imaging: Comparison among three different preparations. Invest Radiol, 1994, 29:339
  • 7[7]Kopp AF, Laniado M, Dammann F,et al. MR imaging of the liver with Resovist: Safety, efficacy, and pharmacodynamic properties. Radiology, 1997, 204:749
  • 8[8]Fahlvik AK, Holtz E, Klaveness J. Relaxation effect of paramagnetic and superparamagnetic microspheres in liver and spleen. Magn Res Imag, 1990, 8:363
  • 9[9]Seneterre E, Taourel P, Bouvier Y,et al. Detection of hepatic metastases ferumoxides-enhanced imaging versus unenhanced MR imaging and CT during arterial portography. Radiology, 1996, 200:785
  • 10[10] Josephson L, Lewis J, Jacobs P,et al. The effect of iron oxides on proton relaxivity. Magn Res Imag, 1988, 6:647

同被引文献22

  • 1杨汉丰,周翔平,宋彬,陈宪,白红利,钟克祥,孙家瑜,张红英,张青.肝内局灶性病变菲立磁增强MRI-组织病理相关性研究[J].中华放射学杂志,2005,39(2):181-186. 被引量:2
  • 2Duda SH,Laniado M,Kopp AF,et al.Superparamagnetic iron oxide:detection of focal liver lesions at high-field-strength MR imaging.J Magn Reson Imaging,1994,4:309-314.
  • 3Winter TC III,Freeny PC,Nghiem HV,et al.MR imaging with i.v.superparamagnetic iron oxide:efficacy in the detection of focal hepatic lesions.AJR,1993,161:1191-1198.
  • 4Imai Y,Murakami T,Yoshida S,et al.Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma:correlation with histological grading.Hepatology,2000,32:205-212.
  • 5Mahfouz AE,Hamm B,Taupitz M,et al.Hypervascular liver lesions:differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.Radiology,1993,186:133-138.
  • 6Hamm B,Staks T,Taupitz M,et al.Contrast-enhanced MR imaging of liver and spleen:first experience in humans with a new superparamagnetic iron oxide.J Magn Reson Imaging,1994,4:659-668.
  • 7Hamm B,Staks T,Taupitz M.SHU 555A.A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging.Invest Radiol.1994,29(Suppl 2):S87-S89.
  • 8Reimer P,Rummeny EJ,Daldrup HE,et al.Clinical results with resovist:a phase 2 clinical trial.Radiology,1995,195:489-496.
  • 9Kopp AF,Laniado M,Dammann F,et al.MR imaging of the liver with resovist:Safety,efficacy,and pharmacodynamic properties.Radiology,1997,204:749-756.
  • 10Matsuo M,Kanematsu M,Itoh K,et al.Detection of malignant hepatic tumors:comparison of gadolinium-and ferumoxide-enhanced MR imaging.AJR,2001,177:637-643.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部